FIRST TRIMESTER TRIPLE MARKER

The assay is used for risk assessment of early & late onset Preclampsia (PE) and prenatal screening of chromosomal anomalies (Trisomy 21, 18/13). For Down Syndrome the approximate detection rate is 85-90% with a false positive rate of 5%. The test has detection rate of 96% for early onset PE & 77% for late onset PE at false positivity rate of 10%.

  • Test Type:
  • Pre-test Information:
    Test is valid between 10-13 weeks gestation. Provide details in Maternal Serum Screen requisition form (Form 11) & Preeclampsia screening form (Form 13).
  • Report Delivery:
    Sample by Tue / Thu / Sat 9 am; Report Same Day
  • Components:
    0